189 related articles for article (PubMed ID: 23650190)
1. Asn441 plays a key role in folding and function of the Na+/I- symporter (NIS).
Li W; Nicola JP; Amzel LM; Carrasco N
FASEB J; 2013 Aug; 27(8):3229-38. PubMed ID: 23650190
[TBL] [Abstract][Full Text] [Related]
2. The iodide-transport-defect-causing mutation R124H: a δ-amino group at position 124 is critical for maturation and trafficking of the Na+/I- symporter.
Paroder V; Nicola JP; Ginter CS; Carrasco N
J Cell Sci; 2013 Aug; 126(Pt 15):3305-13. PubMed ID: 23690546
[TBL] [Abstract][Full Text] [Related]
3. The Iodide Transport Defect-Causing Y348D Mutation in the Na
Reyna-Neyra A; Jung L; Chakrabarti M; Suárez MX; Amzel LM; Carrasco N
Thyroid; 2021 Aug; 31(8):1272-1281. PubMed ID: 33779310
[No Abstract] [Full Text] [Related]
4. The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number.
De La Vieja A; Ginter CS; Carrasco N
J Cell Sci; 2004 Feb; 117(Pt 5):677-87. PubMed ID: 14734652
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of a congenital iodide transport defect: G543E impairs maturation and trafficking of the Na+/I- symporter.
De la Vieja A; Ginter CS; Carrasco N
Mol Endocrinol; 2005 Nov; 19(11):2847-58. PubMed ID: 15976004
[TBL] [Abstract][Full Text] [Related]
6. Molecular characterization of V59E NIS, a Na+/I- symporter mutant that causes congenital I- transport defect.
Reed-Tsur MD; De la Vieja A; Ginter CS; Carrasco N
Endocrinology; 2008 Jun; 149(6):3077-84. PubMed ID: 18339708
[TBL] [Abstract][Full Text] [Related]
7. Amino acid residues in transmembrane segment IX of the Na+/I- symporter play a role in its Na+ dependence and are critical for transport activity.
De la Vieja A; Reed MD; Ginter CS; Carrasco N
J Biol Chem; 2007 Aug; 282(35):25290-8. PubMed ID: 17606623
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of anion selectivity and stoichiometry of the Na+/I- symporter (NIS).
Paroder-Belenitsky M; Maestas MJ; Dohán O; Nicola JP; Reyna-Neyra A; Follenzi A; Dadachova E; Eskandari S; Amzel LM; Carrasco N
Proc Natl Acad Sci U S A; 2011 Nov; 108(44):17933-8. PubMed ID: 22011571
[TBL] [Abstract][Full Text] [Related]
9. Na(+)/I(-) symporter activity requires a small and uncharged amino acid residue at position 395.
Dohán O; Gavrielides MV; Ginter C; Amzel LM; Carrasco N
Mol Endocrinol; 2002 Aug; 16(8):1893-902. PubMed ID: 12145342
[TBL] [Abstract][Full Text] [Related]
10. The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane.
Martín M; Salleron L; Peyret V; Geysels RC; Darrouzet E; Lindenthal S; Bernal Barquero CE; Masini-Repiso AM; Pourcher T; Nicola JP
FASEB J; 2021 Aug; 35(8):e21681. PubMed ID: 34196428
[TBL] [Abstract][Full Text] [Related]
11. A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter.
Martín M; Modenutti CP; Peyret V; Geysels RC; Darrouzet E; Pourcher T; Masini-Repiso AM; Martí MA; Carrasco N; Nicola JP
Endocrinology; 2019 Jan; 160(1):156-168. PubMed ID: 30496374
[TBL] [Abstract][Full Text] [Related]
12. Na+ coordination at the Na2 site of the Na+/I- symporter.
Ferrandino G; Nicola JP; Sánchez YE; Echeverria I; Liu Y; Amzel LM; Carrasco N
Proc Natl Acad Sci U S A; 2016 Sep; 113(37):E5379-88. PubMed ID: 27562170
[TBL] [Abstract][Full Text] [Related]
13. The sodium/iodide symporter: state of the art of its molecular characterization.
Darrouzet E; Lindenthal S; Marcellin D; Pellequer JL; Pourcher T
Biochim Biophys Acta; 2014 Jan; 1838(1 Pt B):244-53. PubMed ID: 23988430
[TBL] [Abstract][Full Text] [Related]
14. Extending the clinical heterogeneity of iodide transport defect (ITD): a novel mutation R124H of the sodium/iodide symporter gene and review of genotype-phenotype correlations in ITD.
Szinnai G; Kosugi S; Derrien C; Lucidarme N; David V; Czernichow P; Polak M
J Clin Endocrinol Metab; 2006 Apr; 91(4):1199-204. PubMed ID: 16418213
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane helix 7 in the Na+/dicarboxylate cotransporter 1 is an outer helix that contains residues critical for function.
Pajor AM; Sun NN; Joshi AD; Randolph KM
Biochim Biophys Acta; 2011 Jun; 1808(6):1454-61. PubMed ID: 21073858
[TBL] [Abstract][Full Text] [Related]
16. An Intramolecular Ionic Interaction Linking Defective Sodium/Iodide Symporter Transport to the Plasma Membrane and Dyshormonogenic Congenital Hypothyroidism.
Bernal Barquero CE; Martín M; Geysels RC; Peyret V; Papendieck P; Masini-Repiso AM; Chiesa AE; Nicola JP
Thyroid; 2022 Jan; 32(1):19-27. PubMed ID: 34726525
[No Abstract] [Full Text] [Related]
17. Novel Sodium/Iodide Symporter Compound Heterozygous Pathogenic Variants Causing Dyshormonogenic Congenital Hypothyroidism.
Martín M; Bernal Barquero CE; Geysels RC; Papendieck P; Peyret V; Masini-Repiso AM; Chiesa AE; Nicola JP
Thyroid; 2019 Jul; 29(7):1023-1026. PubMed ID: 31115276
[TBL] [Abstract][Full Text] [Related]
18. Sodium/Iodide Symporter Mutant V270E Causes Stunted Growth but No Cognitive Deficiency.
Nicola JP; Reyna-Neyra A; Saenger P; Rodriguez-Buritica DF; Gamez Godoy JD; Muzumdar R; Amzel LM; Carrasco N
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1353-61. PubMed ID: 26204134
[TBL] [Abstract][Full Text] [Related]
19. N-linked glycosylation of the thyroid Na+/I- symporter (NIS). Implications for its secondary structure model.
Levy O; De la Vieja A; Ginter CS; Riedel C; Dai G; Carrasco N
J Biol Chem; 1998 Aug; 273(35):22657-63. PubMed ID: 9712895
[TBL] [Abstract][Full Text] [Related]
20. Identification of a structural requirement for thyroid Na+/I- symporter (NIS) function from analysis of a mutation that causes human congenital hypothyroidism.
Levy O; Ginter CS; De la Vieja A; Levy D; Carrasco N
FEBS Lett; 1998 Jun; 429(1):36-40. PubMed ID: 9657379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
